Xylem Inc.

Xylem (XYL) reported strong Q4 2024 results, exceeding revenue expectations and demonstrating 6.5% year-over-year growth [7]. While the stock dipped slightly after the report [7], analysts project continued growth, with estimates of 9.1% earnings growth and 2.2% sales growth for the current fiscal year [2]. Long-term prospects look positive, driven by demand for water solutions and strategic acquisitions like Idrica and Evoqua [4], [5]. However, declining return on invested capital (ROIC) [3] and headwinds in the Applied Water segment [4] pose potential challenges. The upcoming Q1 2025 earnings release on April 29th [6] will be crucial for assessing XYL's performance and validating its growth trajectory.